Mizuho defends Immuneering Corporation (IMRX), 'recommend being opportunistic on IMRX'
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh reiterated an Outperform rating and $12.00 price target on Immuneering Corporation (NASDAQ: IMRX).The analyst commented: "With ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
